The Kroger Company will settle its opioids lawsuit in West Virginia by paying $68 million. In this case, the retailer was accused of contributing to the oversupply of the said drugs that are legally available with a prescription.
The state of West Virginia also alleged that Kroger failed to control the sale of opioids which is a type of drug that includes heroin which is illegal. Synthetic opioids like fentanyl and pain relievers are being sold to patients with prescriptions so they can be purchased in leading drug stores.
Patrick Morrisey, the West Virginia Attorney General, confirmed on Thursday, May 3, that Kroger has settled the lawsuit. The Cincinnati, Ohio-headquartered retail chain is the last defendant in the case, which also involves other major drug stores in the United States, including Rite Aid, Walgreens, CVS, and Walmart.
“Although the hundreds of millions of dollars we secured from these companies will not bring back the lives lost from the opioid menace, our hope is that the money would provide significant help to those affected the most by this crisis in the state,” the attorney general said in a statement.
On the other hand, Kroger’s spokesman also commented that while the company “continues to believe that the allegations made against Kroger in this and other opioid lawsuits are without merit, we have decided that a settlement is the best path forward to resolve this litigation.”
At any rate, CNN Business reported that despite the hefty payment to resolve the opioid suit, the financial impact on Kroger will remain minimal. This is because it reported $4.1 billion in earnings in 2022.
Walgreens also settled with the state of West Virginia in January this year and paid $83 million, while CVS and Walmart resolved the suit with settlements of $82.5 million and $65 million, respectively, in late 2022. In the case of Rite Aid, it paid up to $30 million in August of last year.
Photo by: Mike Kalasnik/Flickr (CC BY-SA 2.0)


Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand
Salesforce Q1 FY2027 Earnings Beat Expectations Despite Soft Q2 Revenue Outlook
U.S. Launches New Strikes on Iran as Trump Signals Peace Deal Uncertainty
Oil Prices Set for Sharp Weekly Losses as U.S.-Iran Ceasefire Hopes Ease Supply Concerns
Autodesk Beats Q1 Estimates, Acquires MaintainX for $3.6 Billion
Asian Currencies Steady as U.S.-Iran Ceasefire Extension Hopes Weigh on Dollar
Oil Prices Jump After New U.S. Strikes on Iran Raise Supply Concerns
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
DOJ Investigates Group Linked to Reid Hoffman Over E. Jean Carroll Lawsuit Funding
SpaceX IPO Could Become Largest in History with $1.8 Trillion Valuation Target
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
CTOC Goes Live on Bitget Wallet Trading, Expanding Global Access to AI-Powered Healthcare Data Ecosystem
Kentucky School District Secures $27 Million in Social Media Addiction Lawsuit Settlements
European EV Sales Surge in April 2026 as Tesla and Chinese Automakers Gain Ground
Universal Music Group Rejects Pershing Square Takeover Proposal
U.S. Sanctions Iran’s Strait of Hormuz Authority as Global Oil Markets Face Turmoil 



